REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,367,678 | -6.9% | 627,445 | -10.1% | 0.00% | -25.0% |
| Q2 2023 | $18,662,914 | -24.2% | 697,679 | -38.6% | 0.00% | -20.0% |
| Q1 2023 | $24,607,016 | +3.2% | 1,136,058 | +13.5% | 0.01% | 0.0% |
| Q4 2022 | $23,848,989 | +16.2% | 1,001,217 | -3.8% | 0.01% | 0.0% |
| Q3 2022 | $20,517,000 | +18.3% | 1,040,426 | +17.0% | 0.01% | +25.0% |
| Q2 2022 | $17,336,000 | -21.8% | 889,497 | +2.3% | 0.00% | -20.0% |
| Q1 2022 | $22,181,000 | +26.9% | 869,507 | +25.3% | 0.01% | +66.7% |
| Q4 2021 | $17,473,000 | -34.8% | 694,203 | -28.7% | 0.00% | -50.0% |
| Q3 2021 | $26,792,000 | +19.9% | 973,898 | +38.3% | 0.01% | +20.0% |
| Q2 2021 | $22,353,000 | -31.1% | 704,257 | -0.3% | 0.01% | -37.5% |
| Q1 2021 | $32,423,000 | +61.5% | 706,691 | +39.4% | 0.01% | +60.0% |
| Q4 2020 | $20,074,000 | +972.3% | 507,066 | +842.6% | 0.01% | +400.0% |
| Q3 2020 | $1,872,000 | -54.0% | 53,794 | -58.3% | 0.00% | 0.0% |
| Q2 2020 | $4,068,000 | +182.7% | 128,850 | +96.2% | 0.00% | 0.0% |
| Q1 2020 | $1,439,000 | – | 65,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |